Dr. Alyson Andreasen Levine, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 150 Purchase St Ste 12f, Rye, NY 10580 Phone: 914-908-3376 Fax: 914-459-1166 |
Dr. Lisa Pham Anthony, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8840 Fax: 914-848-8841 |
Danielle E Engler, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 175 Purchase St, Rye, NY 10580 Phone: 914-967-2153 Fax: 914-967-0453 |
Dr. Meredith Klein Kosann, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 150 Purchase St, Suite 12f, Rye, NY 10580 Phone: 914-908-3376 |
Yoojin Lee, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8840 Fax: 914-848-8841 |
Ruth Kaplan Treiber, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 175 Purchase St, Rye, NY 10580 Phone: 914-967-2153 Fax: 914-967-0453 |
Dr. Jeffrey Mark Barr, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1 Theall Rd, Rye, NY 10580 Phone: 914-848-8840 Fax: 914-848-8841 |
Dr. Eric S Treiber, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 175 Purchase St, Rye, NY 10580 Phone: 914-967-2153 Fax: 914-967-0453 |
News Archive
Cold turkey is the preferred method for giving up smoking according to public health researchers at the University of Sydney. With more than two-thirds of smokers giving up permanently this way the research team wants to know why.
A new pilot study by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) found that breast cancer patients can be treated safely with a "dose-dense" regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin), a drug that has previously been shown to cause cardiac toxicity.
Exposure to common viruses in daycare puts children with a chronic lung condition caused by premature birth at risk for serious respiratory infections, according to a study from Johns Hopkins Children's Center published in the October issue of Pediatrics.
Genmab A/S announced today encouraging results from an ofatumumab Phase II safety and pharmacokinetics study in patients with relapsing-remitting multiple sclerosis (RRMS).
The Washington Post: "Sen. Ben Nelson (Neb.), the final Democratic holdout on health care, was prepared to announce to his caucus Saturday morning that he would support the Senate reform bill, clearing the way for final passage by Christmas."
› Verified 5 days ago